Abstract
This study examines the accumulation of financial and intellectual resources of U.S.-based biopharmaceutical SMEs. We find that internationalized SMEs experience better financial resource growth than domestic market-focused SMEs only in the long run. While international expansion per se does not enable SMEs to accumulate more intellectual resources than via domestic expansion, it exerts a positive impact over time for SMEs with strong alliance capabilities. Moreover, we show that alliance capabilities are more important than in-house technological capabilities for key resource accumulation of internationalized SMEs over time. Our results infer that SMEs gain the benefits of resource exploration via international expansion.
Original language | English |
---|---|
Pages (from-to) | 817-834 |
Number of pages | 18 |
Journal | Journal of World Business |
Volume | 53 |
Issue number | 6 |
DOIs | |
Publication status | Published - Dec 2018 |
Keywords
- Alliance capability
- Biopharmaceutical industry
- Dynamic capability
- Internationalization
- SME
- Technological capability
ASJC Scopus subject areas
- Business and International Management
- Finance
- Marketing